Ética Profesional y Responsabilidad Social Universitaria

este libro compila reflexiones y experiencias en responsabilidad social y ética profesional desde instituciones de Educación Superior. La responsabilidad social universitaria, como ámbito de investigación y de desarrollo conceptual y metodológico es transversal a las universidades, tanto desde el punto de vista organizacional, como desde el misional e investigativo. Quienes impulsen la responsabilidad social, requieren de ética profesional, que debe ser la clave para la construcción de principios que guíen a empresarios, políticos, gestores sociales, investigadores, entre otros, para lograr consensuar el a veces difícil equilibrio entre el bien común y el desarrollo personal

Effect of Hydrocortisone on Mortality and Organ Support in Patients With Severe COVID-19: The REMAP-CAP COVID-19 Corticosteroid Domain Randomized Clinical Trial.

Importance: Evidence regarding corticosteroid use for severe coronavirus disease 2019 (COVID-19) is limited. Objective: To determine whether hydrocortisone improves outcome for patients with severe COVID-19. Design, Setting, and Participants: An ongoing adaptive platform trial testing multiple interventions within multiple therapeutic domains, for example, antiviral agents, corticosteroids, or immunoglobulin. Between March 9 and June 17, 2020, 614 adult patients with suspected or confirmed COVID-19 were enrolled and randomized within at least 1 domain following admission to an intensive care unit (ICU) for respiratory or cardiovascular organ support at 121 sites in 8 countries. Of these, 403 were randomized to open-label interventions within the corticosteroid domain. The domain was halted after results from another trial were released. Follow-up ended August 12, 2020. Interventions: The corticosteroid domain randomized participants to a fixed 7-day course of intravenous hydrocortisone (50 mg or 100 mg every 6 hours) (n = 143), a shock-dependent course (50 mg every 6 hours when shock was clinically evident) (n = 152), or no hydrocortisone (n = 108). Main Outcomes and Measures: The primary end point was organ support-free days (days alive and free of ICU-based respiratory or cardiovascular support) within 21 days, where patients who died were assigned -1 day. The primary analysis was a bayesian cumulative logistic model that included all patients enrolled with severe COVID-19, adjusting for age, sex, site, region, time, assignment to interventions within other domains, and domain and intervention eligibility. Superiority was defined as the posterior probability of an odds ratio greater than 1 (threshold for trial conclusion of superiority >99%). Results: After excluding 19 participants who withdrew consent, there were 384 patients (mean age, 60 years; 29% female) randomized to the fixed-dose (n = 137), shock-dependent (n = 146), and no (n = 101) hydrocortisone groups; 379 (99%) completed the study and were included in the analysis. The mean age for the 3 groups ranged between 59.5 and 60.4 years; most patients were male (range, 70.6%-71.5%); mean body mass index ranged between 29.7 and 30.9; and patients receiving mechanical ventilation ranged between 50.0% and 63.5%. For the fixed-dose, shock-dependent, and no hydrocortisone groups, respectively, the median organ support-free days were 0 (IQR, -1 to 15), 0 (IQR, -1 to 13), and 0 (-1 to 11) days (composed of 30%, 26%, and 33% mortality rates and 11.5, 9.5, and 6 median organ support-free days among survivors). The median adjusted odds ratio and bayesian probability of superiority were 1.43 (95% credible interval, 0.91-2.27) and 93% for fixed-dose hydrocortisone, respectively, and were 1.22 (95% credible interval, 0.76-1.94) and 80% for shock-dependent hydrocortisone compared with no hydrocortisone. Serious adverse events were reported in 4 (3%), 5 (3%), and 1 (1%) patients in the fixed-dose, shock-dependent, and no hydrocortisone groups, respectively. Conclusions and Relevance: Among patients with severe COVID-19, treatment with a 7-day fixed-dose course of hydrocortisone or shock-dependent dosing of hydrocortisone, compared with no hydrocortisone, resulted in 93% and 80% probabilities of superiority with regard to the odds of improvement in organ support-free days within 21 days. However, the trial was stopped early and no treatment strategy met prespecified criteria for statistical superiority, precluding definitive conclusions. Trial Registration: ClinicalTrials.gov Identifier: NCT02735707

Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples

Funder: NCI U24CA211006Abstract: The Cancer Genome Atlas (TCGA) and International Cancer Genome Consortium (ICGC) curated consensus somatic mutation calls using whole exome sequencing (WES) and whole genome sequencing (WGS), respectively. Here, as part of the ICGC/TCGA Pan-Cancer Analysis of Whole Genomes (PCAWG) Consortium, which aggregated whole genome sequencing data from 2,658 cancers across 38 tumour types, we compare WES and WGS side-by-side from 746 TCGA samples, finding that ~80% of mutations overlap in covered exonic regions. We estimate that low variant allele fraction (VAF < 15%) and clonal heterogeneity contribute up to 68% of private WGS mutations and 71% of private WES mutations. We observe that ~30% of private WGS mutations trace to mutations identified by a single variant caller in WES consensus efforts. WGS captures both ~50% more variation in exonic regions and un-observed mutations in loci with variable GC-content. Together, our analysis highlights technological divergences between two reproducible somatic variant detection efforts

Effect of angiotensin-converting enzyme inhibitor and angiotensin receptor blocker initiation on organ support-free days in patients hospitalized with COVID-19

IMPORTANCE Overactivation of the renin-angiotensin system (RAS) may contribute to poor clinical outcomes in patients with COVID-19. Objective To determine whether angiotensin-converting enzyme (ACE) inhibitor or angiotensin receptor blocker (ARB) initiation improves outcomes in patients hospitalized for COVID-19. DESIGN, SETTING, AND PARTICIPANTS In an ongoing, adaptive platform randomized clinical trial, 721 critically ill and 58 non–critically ill hospitalized adults were randomized to receive an RAS inhibitor or control between March 16, 2021, and February 25, 2022, at 69 sites in 7 countries (final follow-up on June 1, 2022). INTERVENTIONS Patients were randomized to receive open-label initiation of an ACE inhibitor (n = 257), ARB (n = 248), ARB in combination with DMX-200 (a chemokine receptor-2 inhibitor; n = 10), or no RAS inhibitor (control; n = 264) for up to 10 days. MAIN OUTCOMES AND MEASURES The primary outcome was organ support–free days, a composite of hospital survival and days alive without cardiovascular or respiratory organ support through 21 days. The primary analysis was a bayesian cumulative logistic model. Odds ratios (ORs) greater than 1 represent improved outcomes. RESULTS On February 25, 2022, enrollment was discontinued due to safety concerns. Among 679 critically ill patients with available primary outcome data, the median age was 56 years and 239 participants (35.2%) were women. Median (IQR) organ support–free days among critically ill patients was 10 (–1 to 16) in the ACE inhibitor group (n = 231), 8 (–1 to 17) in the ARB group (n = 217), and 12 (0 to 17) in the control group (n = 231) (median adjusted odds ratios of 0.77 [95% bayesian credible interval, 0.58-1.06] for improvement for ACE inhibitor and 0.76 [95% credible interval, 0.56-1.05] for ARB compared with control). The posterior probabilities that ACE inhibitors and ARBs worsened organ support–free days compared with control were 94.9% and 95.4%, respectively. Hospital survival occurred in 166 of 231 critically ill participants (71.9%) in the ACE inhibitor group, 152 of 217 (70.0%) in the ARB group, and 182 of 231 (78.8%) in the control group (posterior probabilities that ACE inhibitor and ARB worsened hospital survival compared with control were 95.3% and 98.1%, respectively). CONCLUSIONS AND RELEVANCE In this trial, among critically ill adults with COVID-19, initiation of an ACE inhibitor or ARB did not improve, and likely worsened, clinical outcomes. TRIAL REGISTRATION ClinicalTrials.gov Identifier: NCT0273570

Aplicación de encuestas on-line en el desarrollo de prácticas alimentarias abiertas y encadenadas

On line-surveys were developed in several subjects which employ this kind of tools in order to achieve some of its competences. The implementations of surveys were made in different degrees according with the previous level of knowledge of the students. In this way, students of the subject “Nutrición Aplicada” which belong from the Degree of “Ciencia y Tecnología de Alimentos”, achieved the highest level of implication, developing all the items of the surveys (with supervision of their professors). The educational results were very satisfactory, covering all the transversal and specific competences of multiple subjects. The satisfaction level of the students was also very high. Furthermore, relevant information about dietetic habits of different population groups was obtained.Se han desarrollado encuestas on-line en diferentes asignaturas que tenían el uso de este tipo de herramientas como elementos de apoyo para el desarrollo de alguna de sus competencias. En función de los conocimientos previos de los alumnos y el nivel de formación, la implementación de las encuestas ha requerido una implicación más o menos profunda de los alumnos. En este sentido el grado máximo de implicación se ha realizado en la asignatura Nutrición Aplicada del Grado en Ciencia y Tecnología de los Alimentos, en el que los alumnos han decido e implementado absolutamente todos los aspectos inherentes a la encuesta (supervisado por los profesores). El resultado docente ha sido muy satisfactorio, cubriendo en cada asignatura una o varias competencias transversales y obviamente las específicas relativas al tema de la encuesta. El grado de satisfacción de los alumnos también ha sido elevado. Además la información recopilada tiene un elevado interés en cuanto a conocer aspectos relacionados con la forma de alimentarse de diferentes colectivos.Se han desarrollado encuestas on-line en diferentes asignaturas que tenían el uso de este tipo de herramientas como elementos de apoyo para el desarrollo de alguna de sus competencias. En función de los conocimientos previos de los alumnos y el nivel de formación, la implementación de las encuestas ha requerido una implicación más o menos profunda de los alumnos. En este sentido el grado máximo de implicación se ha realizado en la asignatura Nutrición Aplicada del Grado en Ciencia y Tecnología de los Alimentos, en el que los alumnos han decido e implementado absolutamente todos los aspectos inherentes a la encuesta (supervisado por los profesores). El resultado docente ha sido muy satisfactorio, cubriendo en cada asignatura una o varias competencias transversales y obviamente las específicas relativas al tema de la encuesta. El grado de satisfacción de los alumnos también ha sido elevado. Además la información recopilada tiene un elevado interés en cuanto a conocer aspectos relacionados con la forma de alimentarse de diferentes colectivos

Stadsplanering utifrån ett äldreperspektiv. : En studie om hur sociala konsekvensanalyser kan tillämpas för att utveckla goda livsmiljöer för äldre.

A partir de datos de consumo alimentario de España se han realizado las transformaciones y agrupaciones necesarias para establecer los contenidos nutricionales por toma, en forma de porcentajes, respecto a la ingesta total diaria de cada individuo encuestado (n = 3000). Así mismo, se ha comprobado el efecto de los factores de clasificación (sexo, edad y localidad) sobre la distribución de dichos porcentajes. El resultado del estudio estadístico indica que se deben considerar como grupos diferentes los individuos por debajo de 25 años respecto a los que superan esa edad y que el efecto localidad (entendido como aleatorio y no como fijo) ocasiona diferencias en la distribución de nutrientes entre las tomas de alimentos del día. En cambio, el factor sexo no resultó relevante al encontrarse en tomas anecdóticas las diferencias estadísticamente significativas. Se propone una distribución porcentual de nutrientes concretos entre las diferentes tomas de alimentos.Based on the raw data from the Spanish intake, have made the necessary changes and groupings to establish nutritional content per serving as percentages, regarding the total daily intake of each individual surveyed (n = 3000). Also, it was found the effect of the rating factors (sex, age and location) on the distribution of these percentages. The result indicates that individuals below 25 year should be considered as different groups, front those above that age; and locality effect (treated as random factor rather than fixed) causes differences in the distribution of nutrients between food daily intakes. However, the sex was was not relevant to the anecdotal footage found in statistically significant differences. Percentage distribution of individual nutrients between different food outlets is proposed

Surface Diels–Alder adducts on multilayer graphene for the generation of edge-enriched single-atom FeN4 sites for ORR and OER electrocatalysis

Embargado hasta 15/02/2023The assembly of atomically dispersed iron–nitrogen (FeN4) sites into graphitic structures is a promising approach for sustainable production of bifunctional electrocatalysts for the oxygen electroreduction (ORR) and oxygen evolution (OER) reactions. In addition, single-atom FeN4 sites at the edges of carbon substrates provide higher electrocatalytic performance than those in plane. Unfortunately, the conventional high-temperature pyrolysis method does not allow the generation of edge-enriched FeN4 single-atom sites. Herein, a novel low-temperature and solvent-free mechanochemical synthesis based on the use of dipyridylpyridazine (dppz) functionalized multilayer graphene as a starting material is proposed for precisely engineered location of these FeN4 active sites at the edges. After careful characterization of these dppz-based materials, the ORR and OER electrocatalytic performance was investigated, demonstrating the efficient formation of FeN4 sites at the edges as well as their excellent bifunctional behavior for the ORR and OER. This work paves the way for the development of sustainable approaches for the generation of edge-enriched FeN4 single atom sites on multilayer graphene structures

Dislipidemias y prevención del ictus: recomendaciones del Grupo de Estudio de Enfermedades Cerebrovasculares de la Sociedad Española de Neurología

Objective: We present an update of the Spanish Society of Neurology's recommendations for prevention of both primary and secondary stroke in patients with dyslipidaemia. Development: We performed a systematic review to evaluate the main aspects of the management of dyslipidaemias in primary and secondary stroke prevention and establish a series of recommendations. Conclusions: In primary prevention, the patient's vascular risk should be determined in order to define target values for low-density lipoprotein cholesterol. In secondary prevention after an atherothrombotic stroke, a target value <55 mg/dL is recommended; in non-atherothombotic ischaemic strokes, given the unclear relationship with dyslipidaemia, target value should be established according to the vascular risk group of each patient. In both primary and secondary prevention, statins are the drugs of first choice, and ezetimibe and/or PCSK9 inhibitors may be added in patients not achieving the target value.Objetivo: Actualizar las recomendaciones de la Sociedad Española de Neurología para la prevención del ictus, tanto primaria como secundaria en pacientes con dislipidemia. Desarrollo: Se ha realizado una revisión sistemática en Pubmed evaluando los principales aspectos relacionados con el manejo de las dislipidemias en la prevención primaria y secundaria del ictus, elaborándose una serie de recomendaciones relacionadas con los mismos. Conclusiones: En prevención primaria se recomienda determinar el riesgo vascular del paciente con el fin de definir los objetivos de LDLc. En prevención secundaria tras un ictus de origen aterotrombótico se recomienda un objetivo de LDLc < 55 mg/dl, mientras que en ictus isquémicos de origen no aterotrombótico dado que su relación con dislipidemias es incierta se establecerán los objetivos en base al grupo de riesgo vascular de cada paciente. Tanto en prevención primaria como secundaria las estatinas son los fármacos de primera elección, pudiendo asociarse ezetimiba y/o inhibidores de PCSK9 en aquellos casos que no alcancen los objetivos terapéuticos

Activity of Chloroformic Extract from <i>Salvia connivens</i> (Lamiales: Lamiaceae) and Its Principal Compounds against <i>Spodoptera frugiperda</i> (Lepidoptera: Noctuidae)

Spodoptera frugiperda (Smith) (Lepidoptera: Noctuidae) is one of the most damaging pests in maize crops. In order to manage it, synthetic insecticides such as diamides, neonicotinoids, and pyrethroids are used, but they present a risk for humans and the environment. Investigations of safer alternatives include the use of natural extracts. Thus, this research evaluated the effects of chloroform extract (CHCl3Sc) (5000, 4000, 2000, 1000, and 500 ppm) on aerial parts of Salvia connivens and of nonanal and pyrocatechol (1000, 600, 400, and 80 ppm) on S. frugiperda mortality, duration of the larva and pupae phases, and pupae weight after 24 h. The second instars of S. frugiperda larvae were fed an artificial diet incorporating the extract and compounds. The CHCl3Sc had insecticidal activity against S. frugiperda, showing an LC50 of 1504 ppm. Insectistatic activity began at 1000 ppm, increasing pupal and larval duration in 7.6 and 1.4 days, respectively. Pyrocatechol and nonanal were found in this extract. The first did not have any significant difference in larval or pupal mortalities. On the other hand, insectistatic activity was shown at 500 ppm, increasing the larval duration by 1.7 days compared with the control. In the case of nonanal, the insecticide activity was LC50 of 200 ppm, and insectistatic activity started at 80 ppm, increasing larval duration by 3.2 days compared with the control and reducing pupal weight by 3.4%. The results show that chloroformic extract had insecticidal and insectistatic activities against S. frugiperda; nonanal was an aldehyde compound present in this extract, which confers insecticidal and insectistatic activities against this pest